{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:04:43Z","timestamp":1790129083875,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.neurot.2026.e00969","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:17:26Z","timestamp":1784776646000},"page":"e00969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Site-targeted proximal complement C3 inhibition, but not C5 blockade, attenuates neurodegeneration in a mouse model of amyotrophic lateral sclerosis: Implications for failed clinical trials"],"prefix":"10.1016","volume":"23","author":[{"given":"Moumita","family":"Majumder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis M.","family":"Borucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nityananda","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Mallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurot.2026.e00969_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-4-3","article-title":"Amyotrophic lateral sclerosis","volume":"4","author":"Wijesekera","year":"2009","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00969_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1056\/NEJMra1603471","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Brown","year":"2017","journal-title":"N Engl J Med"},{"issue":"1-2","key":"10.1016\/j.neurot.2026.e00969_bib3","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2011.03.011","article-title":"Complement upregulation and activation on motor neurons and neuromuscular junction in the SOD1 G93A mouse model of familial amyotrophic lateral sclerosis","volume":"235","author":"Heurich","year":"2011","journal-title":"J Neuroimmunol"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00969_bib4","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/jamaneurol.2023.2851","article-title":"Efficacy and safety of ravulizumab, a complement C5 inhibitor, in adults with amyotrophic lateral sclerosis: a randomized clinical trial","volume":"80","author":"Genge","year":"2023","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00969_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.59058","article-title":"Efficacy and safety of zilucoplan in amyotrophic lateral sclerosis: a randomized clinical trial","volume":"8","author":"Paganoni","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00969_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40478-021-01179-6","article-title":"Complement mediates neuroinflammation and cognitive decline at extended chronic time points after traumatic brain injury","volume":"9","author":"Mallah","year":"2021","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00969_bib8","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1172\/JCI22906","article-title":"Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response","volume":"115","author":"Peng","year":"2005","journal-title":"J Clin Investig"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00969_bib9","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1172\/JCI25208","article-title":"Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection","volume":"115","author":"Atkinson","year":"2005","journal-title":"J Clin Investig"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00969_bib10","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.4049\/jimmunol.181.11.8068","article-title":"A novel targeted inhibitor of the alternative pathway of complement and its therapeutic application in ischemia\/reperfusion injury","volume":"181","author":"Huang","year":"2008","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00969_bib11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: a user\u2019s guide","volume":"10","author":"Brooks","year":"2009","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00969_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14660820510026162","article-title":"Optimal methods to characterize the G93A mouse model of ALS","volume":"6","author":"Miana-Mena","year":"2005","journal-title":"Amyotroph Lateral Scler"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00969_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111058","article-title":"Treadmill exercise reduces alpha-synuclein spreading via PPARalpha","volume":"40","author":"Dutta","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.neurot.2026.e00969_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1742-2094-10-119","article-title":"Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Lee","year":"2013","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurot.2026.e00969_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.bbr.2017.05.042","article-title":"Characterization of long-term gait deficits in mouse dMCAO, using the CatWalk system","volume":"331","author":"Caballero-Garrido","year":"2017","journal-title":"Behav Brain Res"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00969_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.428","article-title":"Sectioning and counting of motor neurons in the L3 to L6 region of the adult mouse spinal cord","volume":"2","author":"Austin","year":"2022","journal-title":"Curr Protoc"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00969_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s13311-013-0253-y","article-title":"Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice","volume":"11","author":"Mancuso","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"49","key":"10.1016\/j.neurot.2026.e00969_bib18","doi-asserted-by":"crossref","first-page":"20960","DOI":"10.1073\/pnas.0911405106","article-title":"Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice","volume":"106","author":"Chiu","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.neurot.2026.e00969_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.575792","article-title":"Very early involvement of innate immunity in peripheral nerve degeneration in SOD1-G93A mice","volume":"11","author":"Angelini","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.neurot.2026.e00969_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120156","article-title":"The panoramic view of amyotrophic lateral sclerosis: a fatal intricate neurological disorder","volume":"288","author":"Dhasmana","year":"2022","journal-title":"Life Sci"},{"issue":"Pt 9","key":"10.1016\/j.neurot.2026.e00969_bib21","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1093\/brain\/awr193","article-title":"Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis","volume":"134","author":"Ferraiuolo","year":"2011","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00969_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/jpm10030101","article-title":"Molecular and cellular mechanisms affected in ALS","volume":"10","author":"Le Gall","year":"2020","journal-title":"J Personalized Med"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00969_bib23","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn1971","article-title":"Molecular biology of amyotrophic lateral sclerosis: insights from genetics","volume":"7","author":"Pasinelli","year":"2006","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00969_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2006.12.015","article-title":"Lost in translation: treatment trials in the SOD1 mouse and in human ALS","volume":"26","author":"Benatar","year":"2007","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00969_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ana.10561","article-title":"Of mice and men: reconciling preclinical ALS mouse studies and human clinical trials","volume":"53","author":"Rothstein","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurot.2026.e00969_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fimmu.2015.00417","article-title":"Complement in the homeostatic and ischemic brain","volume":"6","author":"Alawieh","year":"2015","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00969_bib27","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2014.03.004","article-title":"Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice","volume":"234","author":"Liu","year":"2014","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00969_bib28","doi-asserted-by":"crossref","first-page":"7763","DOI":"10.4049\/jimmunol.175.11.7763","article-title":"In vivo correction of complement regulatory protein deficiency with an inhibitor targeting the red blood cell membrane","volume":"175","author":"Spitzer","year":"2005","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00969_bib29","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2353\/ajpath.2006.060248","article-title":"Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma","volume":"169","author":"Qiao","year":"2006","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.neurot.2026.e00969_bib30","doi-asserted-by":"crossref","first-page":"7860","DOI":"10.4049\/jimmunol.179.11.7860","article-title":"A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA\/1J mice","volume":"179","author":"Song","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.neurot.2026.e00969_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102228","article-title":"Sex biology in amyotrophic lateral sclerosis","volume":"95","author":"Zamani","year":"2024","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00969_bib32","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0388-19.2020","article-title":"Sex-specific differences in motor-unit remodeling in a mouse model of ALS","volume":"7","author":"Martineau","year":"2020","journal-title":"eNeuro"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00969_bib33","first-page":"537","article-title":"Neuroinflammation in motor neuron disease","volume":"77","author":"Komine","year":"2015","journal-title":"Nagoya J Med Sci"},{"issue":"8","key":"10.1016\/j.neurot.2026.e00969_bib34","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1523\/JNEUROSCI.1734-20.2020","article-title":"Complement drives synaptic degeneration and progressive cognitive decline in the chronic phase after traumatic brain injury","volume":"41","author":"Alawieh","year":"2021","journal-title":"J Neurosci"},{"issue":"441","key":"10.1016\/j.neurot.2026.e00969_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao6459","article-title":"Targeted complement inhibition salvages stressed neurons and inhibits neuroinflammation after stroke in mice","volume":"10","author":"Alawieh","year":"2018","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00969_bib36","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1523\/JNEUROSCI.2197-17.2018","article-title":"Identifying the role of complement in triggering neuroinflammation after traumatic brain injury","volume":"38","author":"Alawieh","year":"2018","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00969_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23062943","article-title":"A role of complement in the pathogenic sequelae of mouse neonatal germinal matrix hemorrhage","volume":"23","author":"Alshareef","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00969_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-016-0538-2","article-title":"Complement activation at the motor end-plates in amyotrophic lateral sclerosis","volume":"13","author":"Bahia","year":"2016","journal-title":"J Neuroinflammation"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792600139X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792600139X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:09:29Z","timestamp":1790125769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187874792600139X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S187874792600139X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00969","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Site-targeted proximal complement C3 inhibition, but not C5 blockade, attenuates neurodegeneration in a mouse model of amyotrophic lateral sclerosis: Implications for failed clinical trials","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00969"}}